The website of the Clinical Services Journal

Coeliac screening: benefits and barriers

A recent report looking at the possible advantages of mass screening for coeliac disease found that screening of people in high-risk groups could offer benefits. SUZANNE CALLANDER reports.

Despite being one of the most common life-long health conditions in Europe, many people with coeliac disease remain undiagnosed. However, evidence shows that lengthy diagnostic delays do have a negative effect on quality of life and can reduce life-expectancy. The condition is estimated to affect 1% of the European population. It is genetically-determined and causes inflammation to the small intestine, leading to diarrhoea, weight loss and fatigue. Women with coeliac disease can also suffer from repeated, early miscarriages. 

A recent report from Ludvigsson et al,1 published in the UEG Journal, looks at the benefits and barriers to screening for coeliac disease using serologic testing methods in high-risk groups as well as in the general population. The report concluded that screening of first-degree relatives of people with coeliac disease, people with type 1 diabetes, irondeficiency anaemia, Down’s syndrome and other high-risk groups may be appropriate.

“This latest research highlights the value of serologic testing for coeliac disease, particularly for those patients with symptoms that might be due to the condition and in all asymptomatic individuals from high-risk groups,” said Professor Antonio Gasbarrini, director Internal Medicine and Gastroenterology Division at Gemelli University Hospital in Rome, Italy. “It is vital that we start to take positive action across Europe to tackle this prevalent condition and reduce its serious health consequences.”

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.
Register

Upcoming Events

Central Sterilising Club - Annual Scientific Meeting 2024

Crowne Plaza at Gerrard’s Cross
15th April 2024 – 16th April 2024

DECON UK 2024

National Conference Centre, Birmingham
17th April 2024

Infection Prevention & Control

National Conference Centre, Birmingham
23rd - 24th April 2024

Theatres & Decontamination Conference 2024

Coventry Building Society Arena
16th May 2024

The AfPP Roadshow - Birmingham

Millennium Point, Birmingham
18th May 2024

The AfPP Roadshow - Exeter

University of Exeter
22nd June 2024

Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.

Download the FREE Clinical Services Journal app from your device's App store

Upcoming Events

Central Sterilising Club - Annual Scientific Meeting 2024

Crowne Plaza at Gerrard’s Cross
15th April 2024 – 16th April 2024

DECON UK 2024

National Conference Centre, Birmingham
17th April 2024

Infection Prevention & Control

National Conference Centre, Birmingham
23rd - 24th April 2024

Theatres & Decontamination Conference 2024

Coventry Building Society Arena
16th May 2024

The AfPP Roadshow - Birmingham

Millennium Point, Birmingham
18th May 2024

The AfPP Roadshow - Exeter

University of Exeter
22nd June 2024

Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.

Download the FREE Clinical Services Journal app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025